摘要
目的构建人转化生长因子-β1(TGF-β1)基因的原核表达载体,表达并纯化GST-hTGFβ1.方法应用RT-PCR获得人TGF-β1的基因片段,成功构建人TGF-β1原核表达载体,诱导表达人TGF-β1与GST的融合蛋白;应用亲和层析法纯化重组融合蛋白,对纯化产物进行SDS-PAGE电泳分析和Western Blot检测分析.结果成功构建了人TGF-β1重组融合表达质粒pGEX-4T-1-TGF-β1,表达的蛋白经SDS-PAGE电泳分析,在Mr约为39×103处出现了一条新生的蛋白条带,该表达蛋白具有与TGF-β1抗体特异性的结合能力.结论成功构建了人TGF-β1基因的原核表达载体并纯化了该基因的原核表达产物,为下一步的人TGF-β1自体疫苗的研制奠定了基础.
AIM: To clone, express and purify human transforming growth factor β1 (TGF-β1) in E. coli. METHODS: A 336 bp of human rhTGF-β1 gene fragment was obtained by RT-PCR and cloned into pGEX-4T-1 vector, a GST fusion expression vector. The plasmid was transformed into E. coli DH5α and induced to express fusion protein GST- rhTGF-β1 with IPTG. The expression of rhTGF-β1 was detected by SDS-PAGE and Western Blot. RESULTS: A novel protein with expected molecular mass was expressed. The expressed product showed a good binding ability to anti-rhTGF-β1 monoclonal antibody. CONCLUSION : Our successful cloning and expression of rhTGF-β1 gene and purification of rhTGF-β1 protein lay a basis for the production of rhTGF-β1 autovaccine.
出处
《第四军医大学学报》
北大核心
2006年第3期193-195,共3页
Journal of the Fourth Military Medical University
基金
教育部"长江学者和创新团队发展计划"(IRT0459)